The Ritedose Corporation The Ritedose Corporation

  • HOME
  • ABOUT US
  • MANUFACTURING
  • QUALITY
  • DEVELOPMENT
  • 503B CONTACT US
  • News
  • CONTACT
Team
    The Ritedose Corporation > Team

Jody Chastain

July 19, 2015

Continue reading

Uday Doshi

March 3, 2020

Continue reading

Steven Franchak

February 11, 2019

Continue reading

Angie Koen

July 19, 2015

Continue reading

Mohammad Sadeghi

July 19, 2015

Continue reading

Shawn Collins

September 26, 2018

Continue reading

Ken Weems

March 3, 2020

Continue reading

Julia Bales

March 3, 2020

Continue reading

Carol Morgan

February 11, 2019

Continue reading

Lori Wedemyer

December 16, 2016

Continue reading
  • 1
  • 2

Recent Posts

  • Ritedose Awarded 503B Compounded Medications Agreement with Premier, Inc.
  • Ritedose Launches Two New Single-Dose Syringe Products Amid National Drug Shortage: Bupivacaine Hydrocholoride 0.25% (2.5 mg/mL) and Bupivacaine Hydrocholoride 0.5% (5 mg/mL)
  • Ritedose Launches Critical Single-Dose Syringe Product Amid National Drug Shortage: Lidocaine Hydrochloride 1% 100 mg/10 mL
  • Ritedose Reaches Milestone with Asset Purchase
    Becomes largest generic drug maker of its kind
  • Ritedose Launches New 503B, Single-Dose Syringe Medications for Hospitals: Rocuronium Bromide Injection (50 mg/5mL) and Rocuronium Bromide Injection (100 mg/10mL)

Recent Comments

    Archives

    • January 2023
    • November 2022
    • October 2022
    • February 2022
    • January 2022
    • December 2021
    • September 2021
    • August 2021
    • May 2021
    • April 2021
    • March 2021
    • November 2020
    • August 2020
    • March 2020

    Categories

    • In the News
    • Press Releases
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Recent News

    • Ritedose Awarded 503B Compounded Medications Agreement with Premier, Inc. Posted on 30th January, 2023
    • Ritedose Launches Two New Single-Dose Syringe Products Amid National Drug Shortage: Bupivacaine Hydrocholoride 0.25% (2.5 mg/mL) and Bupivacaine Hydrocholoride 0.5% (5 mg/mL) Posted on 17th November, 2022
    • Ritedose Launches Critical Single-Dose Syringe Product Amid National Drug Shortage: Lidocaine Hydrochloride 1% 100 mg/10 mL Posted on 17th October, 2022

    Post Categories

    • In the News (12)
    • Press Releases (10)
    • Uncategorized (11)

    Search Posts

    The Ritedose Corporation
    1 Technology Circle
    Columbia, SC 29203
    (803) 806-3300

    Copyright © 2022 The Ritedose Corporation. All rights reserved.

    Your ticket for the: Jody Chastain

    Title

    Jody Chastain

    USD

    - - -